Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools
ACS Applied Materials & Interfaces · 19.02.2025 · 17 (7) · 10246-10264
DOI: 10.1021/acsami.4c20275 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 04.02.2025. Verfasst von Yujie Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinar…. Hauptthemen laut MEDLINE: Biocompatible Materials, Neoplasms, Receptors, Chimeric Antigen, Immunotherapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 167 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) immune cell therapies have revolutionized oncology, particularly in hematological malignancies, yet their efficacy against solid tumors remains limited due to challenges such as dense stromal barriers and immunosuppressive microenvironments. With advancements in nanobiotechnology, researchers have developed various strategies and methods to enhance the CAR cell efficacy in solid tumor treatment. In this Review, we first outline the structure and mechanism of CAR-T (T, T cell), CAR-NK (NK, natural killer), and CAR-M (M, macrophage) cell therapies and deeply analyze the potential of these cells in the treatment of solid tumors and the challenges they face. Next, we explore how biomaterials can optimize these treatments by improving the tumor microenvironment, controlling CAR cell release, promoting cell infiltration, and enhancing efficacy. Finally, we summarize the current challenges and potential solutions, emphasize the effective combination of biomaterials and CAR cell therapy, and look forward to its future clinical application and treatment strategies. This Review provides important theoretical perspectives and practical guidance for the future development of more effective solid tumor treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medic…
- Teaching and Research Section of Nuclear Medicine, School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, China.
- Department of Oncology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, Jiangsu 225300, China.
- Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu 215123, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China.
ORCID-Profile: Guangming Zhou, Kai Yang, Pei Pei, Lin Hu
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Key Scientific Research Project of Colleges and Universities of Anhui Province of China
- Gusu Leading Talent Program for Innovation and Entrepreneurship
Zitieren
APA
Song, Y., Wang, Y., Man, J., Xu, Y., Zhou, G., Shen, W., Chao, Y., Yang, K., Pei, P., & Hu, L. (2025). Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools. ACS Applied Materials & Interfaces, 17(7), 10246-10264. https://doi.org/10.1021/acsami.4c20275
Vancouver
Song Y, Wang Y, Man J, Xu Y, Zhou G, Shen W, et al. Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools. ACS Applied Materials & Interfaces. 2025;17(7):10246-10264. doi:10.1021/acsami.4c20275
BibTeX
@article{Song2025,
author = {Song, Yujie and Wang, Yifan and Man, Jianping and Xu, Yihua and Zhou, Guangming and Shen, Wenhao and Chao, Yu and Yang, Kai and Pei, Pei and Hu, Lin},
title = {Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {7},
pages = {10246--10264},
doi = {10.1021/acsami.4c20275}
}
EUVIMED